Compare CDNA & TBLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CDNA | TBLA |
|---|---|---|
| Founded | 1998 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.1B |
| IPO Year | 2007 | N/A |
| Metric | CDNA | TBLA |
|---|---|---|
| Price | $17.75 | $3.26 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 5 |
| Target Price | ★ $27.33 | $5.00 |
| AVG Volume (30 Days) | 591.0K | ★ 1.9M |
| Earning Date | 05-13-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $48,324,000.00 | N/A |
| Revenue This Year | $15.37 | $7.95 |
| Revenue Next Year | $11.23 | $5.62 |
| P/E Ratio | ★ N/A | $42.36 |
| Revenue Growth | ★ 18.93 | N/A |
| 52 Week Low | $10.96 | $2.63 |
| 52 Week High | $21.49 | $4.65 |
| Indicator | CDNA | TBLA |
|---|---|---|
| Relative Strength Index (RSI) | 37.96 | 43.39 |
| Support Level | $16.74 | $3.13 |
| Resistance Level | $18.02 | $3.49 |
| Average True Range (ATR) | 0.85 | 0.16 |
| MACD | -0.13 | 0.04 |
| Stochastic Oscillator | 23.20 | 69.11 |
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
Taboola is a performance-based native advertising network designed to improve click-through rates and increase monetizable events for advertisers while generating yield for publisher websites. Taboola competes with Google, Amazon, and other advertising networks that display stories and products on websites. The company was founded in 2007 in Israel. It acquired Connexity, a retail advertising network, in 2021, and entered a partnership with Yahoo in 2022, in which it acquired exclusive native advertising rights over Yahoo digital properties in exchange for a 25% equity stake in the company.